The emergence of coronavirus disease 2019 (COVID-19) and subsequent declaration as a global pandemic by World Health Organization (WHO) led to skyrocketing demand for ventilators. ...
The majority of the funding in A.I. are aimed at the advancement or expansion of the AI-powered drug discovery platforms with additional capabilities and for the acceleration of their international expansion. ...
North American region, especially U.S. has the highest share of AI-based healthcare start-ups. The highly nurturing entrepreneurial ecosystem of the region, availability of immense private funding, several government initiatives for the large scale d...
Start-up is a high-growth potential entrepreneurial venture that is technologically oriented to meet the most pressing need of a marketplace by offering or developing innovative services, products or processes......
Over the decades genomics has contributed immensely in enhancing our knowledge of genes and their interactions with surrounding environment. With the exponential advancements in computational power there has been an......
Artificial intelligence (AI), a constellation of technologies that enables machines to simulate human cognitive functions and with the potential of radically transforming any industry into which it is integrated is being currently slowly deployed int...
Introduction of most sophisticated sensor-based solutions in adult diapers and ostomy bags leading to better care for patients and the development of implantable devices for the treatment of incontinence and ostomy are the leading innovations. ...
Various diagnostic radioisotopes are in phase III clinical trials and are expected to be commercialized in the coming years which includes I-123, Zr-89, Ac-225, Ra-224, I-125, Cu-64 and others....
Technological advancements such as biosticker, artificial intelligence (AI), wearable patient monitoring devices, functional near-infrared spectroscopy (fNIRS), a tricorder phototype for diagnosis and monitoring of multi-parameter, smart speakers for...
The contract biomanufacturers, who provide biopharmaceutical manufacturing services on a fee for service basis, have been quick in the implementation of continuous biomanufacturing to improve scalability and quality of the products produced, in the e...
To meet the persistently elevating demands of easy to use and patient centric structural heart devices with minimal traumatizing effects, reduced infection risk rates, accelerated recovery rates and better therapeutic outcomes, companies and research...
The innovative technologies improved all aspects in cell line development, allowing for higher productivity levels and expression of proteins previously not eligible for manufacturing such as complex, non-natural or difficult-to-express proteins and ...